ERBB2 and neoplasm: The miRNA signatures have been correlated with clinicopathological and prognostic parameters such as tumor size, nodal involvement, vascular invasiveness, ErbB2, estrogen receptor status and chemotherapy resistance [9-11,13,21-24,27,28,30,31].